🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial is designed as a multi-center, open label Phase 2 trial that inve...
Status
Completed
Location
3203; Antwerp University Hospital; Department of Medical Oncology
Start Date
2011-07
Trial ID
NCT01417936
Treatments Being Tested
This is a phase 1b/2b study investigating the safety and preliminary antitu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02924233
This is a single arm, phase 2, open-label, multicenter trial in patients wi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02965417
Treatments Being Tested
This is a randomized phase III study with a safety lead-in part in patients...
Status
Terminated
Location
University of Michigan Oncology Clinic | Rogel Cancer Center
Start Date
2022-04-21
Trial ID
NCT05223673
Treatments Being Tested
This trial is to assess the safety and tolerability of Sym004, administered...
Status
Completed
Location
Please contact the Merck KGaA Communication Center located in
Start Date
2013-10-31
Trial ID
NCT01955473
Treatments Being Tested
This trial is designed as a multi-centre, open label, dose-escalation, phas...
Status
Completed
Location
South Texas Accelerated Research Therapeutics (START)
Start Date
2010-03
Trial ID
NCT01117428
Treatments Being Tested
This is a multi-center, open-label, Phase 1b, dose escalation trial of Sym0...
Status
Terminated
Location
Please Contact U.S. Medical Information Located in
Start Date
2014-07
Trial ID
NCT02083679
This is a Phase 3, randomized, open-label, 2-arm trial designed to evaluate...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02
Trial ID
NCT03717038
This is a Phase 1b/2a study investigating the safety and efficacy of Sym004...
Status
Terminated
Location
UCLA School of Medicine
Start Date
2016-03-15
Trial ID
NCT02568046
This is a Phase 2, open-label, randomized, 3-arm trial investigating the ef...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2014-03-06
Trial ID
NCT02083653
Treatments Being Tested